Standard Nuclear plans to list on the New York Stock Exchange this week, offering 18.25 million shares in a range of $18.00 to $21.00 per share -- a deal that would raise approximately $356 million at the $19.50 midpoint and value the company at roughly $3.3 billion. The proceeds are explicitly earmarked to fund the company's build-out of small modular reactors (SMRs), a next-generation nuclear technology increasingly viewed as a faster, more flexible way to add dedicated power capacity than traditional large-scale reactors.
The listing sits inside one of 2026's clearest energy-infrastructure investment themes: AI data centers are driving power-demand growth that traditional grid buildout simply can't keep pace with on the timelines hyperscalers need, pushing both public and private capital toward dedicated, faster-to-deploy generation sources like SMRs. Standard Nuclear isn't alone in pursuing a public listing on this thesis -- Holtec Nuclear has separately filed for its own Nasdaq listing to fund SMR expansion, meaning two nuclear-focused IPOs are effectively competing for the same investor base within weeks of each other.
“That's a meaningfully different opportunity set than the software and model-layer IPOs that dominated headlines earlier in the AI cycle.”
The timing pairing with Csquare's roughly $1.25 billion data-center IPO the same week is not a coincidence -- it reflects a genuine, thematically coherent moment in the public markets where investors are being offered the chance to buy both sides of the AI power equation (generation and consumption infrastructure) within the same trading week. That's a meaningfully different opportunity set than the software and model-layer IPOs that dominated headlines earlier in the AI cycle.
For energy and infrastructure investors, Standard Nuclear's IPO is a test of how much public-market capital is genuinely available for pre-revenue or early-revenue nuclear buildout, a category that historically required patient, multi-decade capital rather than the faster return cycles typical of public equity investors. A successful pricing and aftermarket performance would validate SMRs as a public-markets-fundable category well beyond the government contracts and private capital that have funded the sector to date.
The bear case: SMR technology remains commercially unproven at scale, with long regulatory approval timelines and construction-cost overruns a persistent risk across the nuclear industry historically, and Standard Nuclear's roughly $3.3 billion valuation prices in successful execution on a technology that hasn't yet been proven at commercial scale. What to watch next: how Standard Nuclear's stock performs relative to Holtec Nuclear's competing listing, and whether either company secures binding hyperscaler power-purchase agreements that would validate the demand thesis underpinning both IPOs.